Please login to your online account to display your discounted pricing

Sino Biological™ CD84 Recombinant Human Protein, His Tag DFS Item


This recombinant protein was expressed from a DNA sequence encoding the extracellular domain (Met 1-Gly 225) of human CD84 (NP_003865.1) fused to a polyhistidine tag at the C-terminus

Manufacturer: life technologies  LS10100H08H250

 View more versions of this product

 Disclaimers

For Research Use Only. Not for use in diagnostic procedures.

Catalog No. 10100H08HL

  • / Each
 

Description & Specifications

Specifications

Structural Form Truncated/Recombinant/Cell Surface Protein
Molecular Weight 24kDa
Quantity 5 x 50μg
Gene ID (Entrez) 8832
Gene Alias DKFZp781E2378, LY9B, SLAMF5, hCD84, mCD84.
For Use With (Application) Proteins, Expression, Isolation & Analysis; Enzyme & Protein Activity Assays; Protein Assay Controls, Reference Standards & Accessories
Purity ≥90% by SDS-PAGE
Storage Requirements Store at -20° to -70°C. Store aliquots under sterile conditions at -20°C. Avoid repeated freeze-thaw cycles. Expires one year from date of receipt when stored as instructed.
Common Name CD84 molecule
Gene Symbol CD84
Expression System Mammalian
Protein Subtype Other Proteins
Endotoxin Concentration <1 EU/μg
Validated Application Assay Standard
Protein Tag His Tag
Protein Family CD Proteins
Format Lyophilized

Cluster of Differentiation 84 (CD84), recombinant human protein is supplied as a lyophilized powder. It is suitable for use in analysis of protein structure. In general, recombinant proteins can also be used as an immunogen, as a protein standard, or in cell biology research applications.

  • Activity: This recombinant protein has not been tested
  • Formulation: Lyophilized in PBS, pH 7.4, 5% Mannitol, 5% Trehalose, and 0.02% Tween 80
  • Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible

Shipping Condition: Room Temperature. This protein is manufactured by Sino Biological Inc.